Nanalysis Scientific Corp. (TSXV:NSCI)
0.1550
+0.0200 (14.81%)
Apr 21, 2026, 2:44 PM EST
Nanalysis Scientific Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.55 | 1.38 | 0.76 | 3.53 | 10.41 |
Cash & Short-Term Investments | 0.55 | 1.38 | 0.76 | 3.53 | 10.41 |
Cash Growth | -60.39% | 81.29% | -78.47% | -66.12% | 229.48% |
Accounts Receivable | 7.61 | 10.11 | 8.35 | 7.14 | 4.97 |
Other Receivables | 0.9 | 0.96 | 1.41 | 1.85 | 1.13 |
Receivables | 8.5 | 11.07 | 9.76 | 8.98 | 6.1 |
Inventory | 3.65 | 4.39 | 5.79 | 7.39 | 3.68 |
Prepaid Expenses | 1.43 | 1.43 | 1.6 | 2.06 | 0.58 |
Restricted Cash | 2.61 | - | - | - | - |
Total Current Assets | 16.74 | 18.26 | 17.91 | 21.96 | 20.76 |
Property, Plant & Equipment | 2.18 | 2.89 | 4.74 | 6.42 | 2.54 |
Long-Term Investments | - | - | 5.73 | - | - |
Goodwill | 5.7 | 5.7 | 5.7 | 13.08 | 0.39 |
Other Intangible Assets | 2 | 1.92 | 3.47 | 3.71 | 1.62 |
Long-Term Accounts Receivable | 0.12 | 0.34 | - | 0.77 | - |
Long-Term Deferred Tax Assets | - | - | - | 0.1 | - |
Long-Term Deferred Charges | 10.39 | 11.12 | 12.47 | 22.91 | 12.48 |
Other Long-Term Assets | 1.3 | 2.14 | 3.11 | 0.94 | - |
Total Assets | 38.41 | 42.37 | 53.82 | 69.9 | 37.79 |
Accounts Payable | 5.2 | 5.83 | 5.08 | 5.76 | 4.44 |
Short-Term Debt | 2.8 | 2.8 | 2.9 | 2.54 | - |
Current Portion of Long-Term Debt | 6.99 | 3.22 | 3.59 | 1.11 | 1.94 |
Current Portion of Leases | 0.78 | 0.83 | 0.8 | 0.79 | 0.26 |
Current Unearned Revenue | 1.25 | 1.19 | 1.32 | 1.93 | 1.8 |
Other Current Liabilities | 0.18 | 0.52 | 0.91 | 1.38 | 0.21 |
Total Current Liabilities | 17.2 | 14.38 | 14.6 | 13.51 | 8.65 |
Long-Term Debt | 6.2 | 10.14 | 12.56 | 3.79 | 2.75 |
Long-Term Leases | 0.81 | 1.38 | 2.13 | 2.53 | 1.04 |
Long-Term Unearned Revenue | 0.55 | 0.65 | 0.88 | 1.12 | 0.82 |
Long-Term Deferred Tax Liabilities | 0.08 | 0.12 | 0.18 | 0.26 | 0.26 |
Other Long-Term Liabilities | 0.15 | 0.16 | - | 1.14 | 0.32 |
Total Liabilities | 24.99 | 26.83 | 30.34 | 22.33 | 13.83 |
Common Stock | 60.2 | 57.57 | 53.2 | 49.02 | 31.3 |
Additional Paid-In Capital | 6.46 | 6 | 4.67 | 3.09 | 1.64 |
Retained Earnings | -54.26 | -48.6 | -34.99 | -18.79 | -9.69 |
Comprehensive Income & Other | 1.02 | 0.58 | 0.6 | 1.82 | 0.71 |
Total Common Equity | 13.42 | 15.55 | 23.48 | 35.13 | 23.96 |
Minority Interest | - | - | - | 12.44 | - |
Shareholders' Equity | 13.42 | 15.55 | 23.48 | 47.57 | 23.96 |
Total Liabilities & Equity | 38.41 | 42.37 | 53.82 | 69.9 | 37.79 |
Total Debt | 17.58 | 18.36 | 21.97 | 10.75 | 5.99 |
Net Cash (Debt) | -17.03 | -16.99 | -21.21 | -7.23 | 4.42 |
Net Cash Per Share | -0.15 | -0.15 | -0.21 | -0.08 | 0.06 |
Filing Date Shares Outstanding | 132.31 | 113.22 | 113.03 | 94.45 | 77.17 |
Total Common Shares Outstanding | 132.31 | 113.22 | 101.92 | 94.45 | 77.17 |
Working Capital | -0.46 | 3.88 | 3.32 | 8.45 | 12.12 |
Book Value Per Share | 0.10 | 0.14 | 0.23 | 0.37 | 0.31 |
Tangible Book Value | 5.73 | 7.93 | 14.31 | 18.33 | 21.95 |
Tangible Book Value Per Share | 0.04 | 0.07 | 0.14 | 0.19 | 0.28 |
Machinery | 4.01 | 3.99 | 3.96 | 4.61 | 2.42 |
Leasehold Improvements | 0.61 | 0.58 | 0.59 | 0.59 | 0.48 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.